ESN-282

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameESN-282
Drug Alias NameG-protein coupled receptor 43 modulator (Ogeda)free fatty acid receptor 2 modulator (Ogeda)GPR43 receptor modulator (Ogeda)ESN-280ESN-284 +[6] 
ClassificationSmall molecules
Mechanisms of ActionFree fatty acid receptor 2 agonistsInsulin sensitizers
TargetsFree fatty acid receptor 2
Therapy Area/IndicationsInflammationDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOgeda SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOgeda SAMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsInflammationDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A